Proprietary AI analyst is now available

SV Investment Valuation Multiples

Discover SV Investment's revenue and EBITDA valuation multiples and investment history, alongside public comparables like DY, Gunosy, Quest for Growth, Atinum Investment and more.

SV Investment Overview

About SV Investment

SV Investment Corp operates as an Investment firm in South Korea. The company provides venture capital, initial public offer, merger and acquisition, operation consulting services and private equity investment services.


Founded

2006

HQ

South Korea

Employees

N/A

Sectors

Financials (FY)

Revenue: $14M
EBITDA: ($3M)

EV

$71M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

SV Investment Financials

SV Investment reported last fiscal year revenue of $14M and negative EBITDA of ($3M).

In the same fiscal year, SV Investment generated $8M in gross profit, ($3M) in EBITDA losses, and had net loss of ($3M).


SV Investment P&L

In the most recent fiscal year, SV Investment reported revenue of $14M and EBITDA of ($3M).

SV Investment is unprofitable as of last fiscal year, with gross margin of 59%, EBITDA margin of (24%), and net margin of (25%).

See analyst estimates for SV Investment
Last FY202320242025202620272028
Revenue$14M$19M$15M$14M
Gross Profit$8M$15M$10M$8M
Gross Margin59%81%66%59%
EBITDA($3M)$4M($1M)($3M)
EBITDA Margin(24%)24%(8%)(24%)
EBIT Margin(29%)21%(13%)(29%)
Net Profit($3M)$3M($2M)($3M)
Net Margin(25%)14%(12%)(25%)

Financial data powered by Morningstar, Inc.

SV Investment Stock Performance

SV Investment has current market cap of $67M, and enterprise value of $71M.

Market Cap Evolution


SV Investment's stock price is $1.23.

SV Investment share price decreased by 30.6% in the last 30 days.

SV Investment has an EPS (earnings per share) of $-0.06.

See more trading valuation data for SV Investment
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$71M$67M0.8%-30.6%--$-0.06

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

SV Investment Valuation Multiples

SV Investment trades at 5.1x EV/Revenue multiple, and (21.7x) EV/EBITDA.

See NTM and 2027E valuation multiples for SV Investment

SV Investment Financial Valuation Multiples

As of June 28, 2026, SV Investment has market cap of $67M and EV of $71M.

SV Investment has a P/E ratio of (19.6x).

Last FY202320242025202620272028
EV/Revenue5.1x3.8x4.7x5.1x
EV/EBITDA(21.7x)16.1x(56.2x)(21.7x)
EV/EBIT(17.9x)18.4x(36.6x)(17.9x)
EV/Gross Profit8.7x4.7x7.1x8.7x
P/E(19.6x)25.1x(35.9x)(19.6x)
EV/FCF(70.9x)(13.7x)(33.8x)(81.6x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified SV Investment Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

SV Investment Margins & Growth Rates

In the most recent fiscal year, SV Investment reported gross margin of 59%, EBITDA margin of (24%), and net margin of (25%).

See estimated margins and future growth rates for SV Investment

SV Investment Margins

Last FY20242025202720282029
Gross Margin59%66%59%
EBITDA Margin(24%)(8%)(24%)
EBIT Margin(29%)(13%)(29%)
Net Margin(25%)(12%)(25%)
FCF Margin(7%)(14%)(6%)

SV Investment Growth Rates

23/2424/2525/2626/2727/2828/29
Revenue Growth(19%)(9%)-
Gross Profit Growth(34%)(18%)-
EBITDA Growth(129%)159%-
EBIT Growth(150%)105%-
Net Profit Growth(170%)83%-
FCF Growth(59%)(59%)(5%)

Data powered by FactSet, Inc. and Morningstar, Inc.

SV Investment Operational KPIs

Access forward-looking KPIs for SV Investment
Last FY202320242025202620272028
S&M Expenses to Revenue11%9%10%11%
G&A Expenses to Revenue6%5%6%6%
Opex to Revenue88%60%78%88%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

SV Investment Competitors

SV Investment competitors include DY, Gunosy, Quest for Growth, Atinum Investment, Alpha, Company K Partners, LB Investment, Argo Blockchain, Software Circle and Brookfield Glb Infr Secs.

Most SV Investment public comparables operate across PE & VC.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
DY0.1x-1.8x-
Gunosy0.8x0.8x18.4x-
Quest for Growth(37.2x)---
Atinum Investment0.7x-1.6x-
Alpha0.3x0.3x6.4x-
Company K Partners3.9x-8.1x-
LB Investment2.2x-5.7x-
Argo Blockchain3.5x-4.5x-

This data is available for Pro users. Sign up to see all SV Investment competitors and their valuation data.

Start Free Trial

Investments by SV Investment

SV Investment has invested in 70 companies to date.

Latest investment by SV Investment was on May 28th 2026. SV Investment invested in XCENA in their $135M Series B round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by SV Investment

XCENA
Asteromorph
Caring
GenEdit
Description
XCENA is a startup designing intelligent memory and memory-centric computing architectures utilizing CXL technology. The company targets high-performance data processing advancements for data centers and AI applications.
Asteromorph is an artificial intelligence research startup advancing models toward scientific superintelligence for complex problem-solving in research domains.
Caring runs visiting medical treatment facilities in South Korea, specializing in home-based consultations for chronic conditions and post-operative recovery. Physicians provide on-site assessments, medication management, and preventive health checkups tailored to elderly patients. Seoul-headquartered, the service integrates telemedicine options and collaborates with local hospitals for seamless referrals.
GenEdit is a South San Francisco-based biotechnology firm developing non-viral nanoparticle delivery systems for gene editing therapies. The NanoGalaxy platform screens billions of lipid nanoparticles to deliver CRISPR-Cas9 and other editors to specific tissues like liver, muscle, and brain. This approach addresses limitations of viral vectors by enabling safer, scalable production. Founded in 2017, GenEdit has raised over $50 million in funding and collaborates with Stanford University researchers. Its technology supports applications in genetic diseases such as muscular dystrophy and liver disorders.
HQ CountrySouth KoreaSouth KoreaSouth KoreaUnited States
HQ City
Seongnam
Seoul
Gangneung
San Francisco, CA
Deal Date28 May 202628 May 20267 May 202625 Feb 2026
RoundSeries BSeedSeries CSeries B
Raised$135M$32M$27M$60M
InvestorsKDB Capital; STIC Ventures; IMM Investment; Korea Development Bank; Kiwoom Investment; SV Investment; K2 Investment Partners; Kyobo Securities; Company K Partners; Partners Investment; Atinum Investment; SBI Investment KOREAKDB Capital; STIC Ventures; IMM Investment; BonAngels Venture Partners; Mirae Asset Venture Investment; SV Investment; Premier Partners; KDB Investment; FuturePlay; Mirae Asset CapitalSTIC Investments; STIC Ventures; IMM Investment; SV Investment; Hyundai Investment PartnersACVC Partners; STIC Ventures; Top Harvest Capital; Woori Venture Partners; DSC Investment; Korea Investment Partners; Dayli Partners; loftyrock investment; Kiwoom Investment; SV Investment; Yuanta Investment; Pathway Investment
Valuation$570Mundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all SV Investment investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About SV Investment

When was SV Investment founded?SV Investment was founded in 2006.
Where is SV Investment headquartered?SV Investment is headquartered in South Korea.
Is SV Investment publicly listed?Yes, SV Investment is a public company listed on Korea Exchange.
What is the stock symbol of SV Investment?SV Investment trades under 289080 ticker.
When did SV Investment go public?SV Investment went public in 2018.
Who are competitors of SV Investment?SV Investment main competitors include DY, Gunosy, Quest for Growth, Atinum Investment, Alpha, Company K Partners, LB Investment, Argo Blockchain, Software Circle, Brookfield Glb Infr Secs.
What is the current market cap of SV Investment?SV Investment's current market cap is $67M.
What is the current revenue of SV Investment?SV Investment's last fiscal year revenue is $14M.
What is the current EV/Revenue multiple of SV Investment?Current revenue multiple of SV Investment is 5.1x.
Is SV Investment profitable?No, SV Investment is not profitable.
How many companies SV Investment has acquired to date?SV Investment hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies SV Investment has invested to date?As of June 2026, SV Investment has invested in 70 companies.
What was the last SV Investment investment?On 28th May 2026 SV Investment invested in XCENA, participating in a $135M Series B round at $570M valuation, alongside KDB Capital, STIC Ventures, IMM Investment, Korea Development Bank, Kiwoom Investment, K2 Investment Partners, Kyobo Securities, Company K Partners, Partners Investment, Atinum Investment, and 1 other investor.
In what companies SV Investment invested in?SV Investment invested in XCENA, GenEdit, MyRealTrip, Amogy, ABLY Corporation, SemiFive, PineTree Therapeutics, SM Lab, Maka Motors, Asteromorph, Caring, Newracle Genetics, 3i, AITRICS, Above Golf Link, AGL, Swit, Innospace, Catch Fashion, Nextchip Co, and 50 other companies.

See public comps similar to SV Investment

Lists including SV Investment

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial